Log in to save to my catalogue

The endothelin axis in cancer : the promise and the challenges of molecularly targeted therapy

The endothelin axis in cancer : the promise and the challenges of molecularly targeted therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69488543

The endothelin axis in cancer : the promise and the challenges of molecularly targeted therapy

About this item

Full title

The endothelin axis in cancer : the promise and the challenges of molecularly targeted therapy

Publisher

Ottawa, ON: National Research Council of Canada

Journal title

Canadian journal of physiology and pharmacology, 2008-08, Vol.86 (8), p.473-484

Language

English

Formats

Publication information

Publisher

Ottawa, ON: National Research Council of Canada

More information

Scope and Contents

Contents

The endothelin (ET) axis, which includes ET-1, ET-2, ET-3, and 2 G protein-coupled receptor subtypes, ET AR and ET BR, promotes growth and progression of a variety of tumors, such as prostatic, ovarian, renal, pulmonary, colorectal, cervical, breast, lung, bladder, endometrial carcinoma, Kaposi's sarcoma, brain tumors, and melanoma. Acting on selec...

Alternative Titles

Full title

The endothelin axis in cancer : the promise and the challenges of molecularly targeted therapy

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_69488543

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69488543

Other Identifiers

ISSN

0008-4212

E-ISSN

1205-7541

DOI

10.1139/Y08-058

How to access this item